Equity Analysis

Quarterly Results

    Jagsonpal Pharmaceuticals Ltd
    Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
    BSE Code
    ISIN Demat
    Book Value()
    507789
    INE048B01035
    29.7045526
    NSE Symbol
    P/E(TTM)
    Mar.Cap( Cr.)
    JAGSNPHARM
    39.97
    1456.38
    EPS(TTM)
    Face Value()
    Div & Yield %:
    5.49
    2
    0.91
     
Quarters
(RupeeIcon Cr)
ParticularsDec 2024Sep 2024Jun 2024
Gross Sales74.0374.6961.44
Other Operating Income0.000.000.00
Other Income 25.511.651.44
Total Income99.5376.3562.88
Total Expenditure 58.1958.4154.49
PBIDT41.3417.948.40
Interest 0.260.230.22
PBDT41.0917.718.18
Depreciation2.412.341.07
Tax8.062.681.59
Fringe Benefit Tax0.000.000.00
Deferred Tax-1.381.230.19
Reported Profit After Tax31.9911.465.33
Extra-ordinary Items 18.350.00-2.46
Adjusted Profit After Extra-ordinary item13.6411.467.79
EPS (Unit Curr.)4.744.291.94
EPS (Adj) (Unit Curr.)1.901.720.78
Calculated EPS (Unit Curr.)4.844.332.01
Calculated EPS (Adj) (Unit Curr.)1.941.730.80
Calculated EPS (Ann.) (Unit Curr.)19.3517.318.06
Calculated EPS (Adj) (Ann.) (Unit Curr.)7.746.923.22
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity13.2313.2413.23
Reserve & Surplus0.000.000.00
Face Value2.005.005.00
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
PBIDTM(%)55.8424.0213.67
PBDTM(%)55.5023.7113.31
PATM(%)43.2115.348.68
Dividend Per Share(Rs)0.000.000.00
Diluted EPS4.744.251.93